Indian stocks slip on virus fears; pharma, Reliance limit losses

Top Stories

The NSE Nifty 50 index fell 0.19 per cent to 10,792.5 by 0454 GMT, while the benchmark S&P BSE Sensex was down 0.24 per cent at 36,648.11. - Reuters
The NSE Nifty 50 index fell 0.19 per cent to 10,792.5 by 0454 GMT, while the benchmark S&P BSE Sensex was down 0.24 per cent at 36,648.11. - Reuters

Bengaluru - Nifty, Sensex down 0.2% each

By Chris Thomas

  • Follow us on
  • google-news
  • whatsapp
  • telegram

Published: Fri 10 Jul 2020, 9:23 AM

Last updated: Fri 10 Jul 2020, 11:37 AM

Indian shares fell on Friday as a relentless surge in domestic coronavirus cases threatened to disrupt an economic recovery, although gains in pharmaceuticals and heavyweight Reliance Industries helped limit losses.
The NSE Nifty 50 index fell 0.19 per cent to 10,792.5 by 0454 GMT, while the benchmark S&P BSE Sensex was down 0.24 per cent at 36,648.11. The indexes were, however, headed for their fourth straight week of gains, after a rally driven by a liquidity flush and hopes for a COVID-19 vaccine.
Cases in the world's second-most populous country jumped by a record 26,506 to 793,802 as of Friday morning, including 21,604 deaths, health ministry data showed.
"Fundamentals are still very shaky at point as virus cases rise, and quarterly results may throw up some negative surprises," said Krish Subramanyam, co-head, equity advisory at Altamount Capital in Mumbai. "Investors may be looking to book some profits after the recent appreciation."
Asian shares and US stock futures too slipped on Friday as record surges in many US states stoked fears of new lockdowns that could hurt an economic recovery.
In Mumbai trading, telecom infrastructure company Bharti Infratel Ltd slid 3.3per cent, while Adani Ports and Special Economic Zone Ltd fell 3.2 per cent to a four-week low.
State-run Punjab National Bank fell 6.7per cent after it reported loans made to shadow lender DHFL worth 36.89 billion rupees ($490.95 million) as "fraud".
Tata Consultancy Services Ltd fell 1.2per cent after the top IT exporter, the first of major Indian corporates to report their June-quarter results, posted a bigger than expected 14per cent drop in profit on Thursday as the pandemic forced its clients to cut spending on IT services.
Meanwhile, the Nifty Pharma Index, the best performer so far this year with gains of more than 24 per cent, was up 1.7 per cent. Sun Pharma climbed 3.2 per cent.
Reliance Industries rose 1.4 per cent after BP paid the conglomerate $1 billion to set up a joint network of thousands of petrol stations across India. - Reuters


More news from